These clonal populations can impact hematopoiesis and are associated with an increased risk of hematological malignancies and cardiovascular disease, making CHIP a valuable biomarker for aging research [49–51, 70, 79–81]. This evidence concerns the gene STUB1 and hematologic disorder.